Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Bacterial Infections

Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation

Clin Infect Dis.

Levy C, Varon E, Ouldali N, Béchet S, Bonacorsi S, Cohen R

doi: 10.1093/cid/ciz221.

Bacterial Infections

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18

Clin Infect Dis.

Amin-Chowdhury Z, Collins S, Sheppard C, Litt D, Fry NK, Andrews N, Ladhani SN

doi: 10.1093/cid/ciaa043.

Viral Infections, Non-HIV

Who is at risk of 13-valent conjugated pneumococcal vaccine failure?

Vaccine.

Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I

doi: 10.1016/j.vaccine.2019.12.060.

Viral Infections, Non-HIV

A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age

Vaccine

Klein NP, Peyrani P, Yacisin K, Caldwell N, Xu X, Scully IL, Scott DA, Jansen KU, Gruber WC, Watson W

doi: 10.1016/j.vaccine.2021.07.004

Bacterial Infections

Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States

JAMA Pediatr.

Mbaeyi S, Pondo T, Blain A, Yankey D, Potts C, Cohn A, Hariri S, Shang N, MacNeil JR

doi: 10.1001/jamapediatrics.2020.1990.

Bacterial Infections

Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016

Vaccine.

Pezzotti P, Bellino S, Riccardo F, Lucaroni F, Cerquetti M, Pantosti A, Rezza G, Stefanelli P

doi: 10.1016/j.vaccine.2018.11.047.

Viral Infections, Non-HIV

Polio endgame: Lessons for the global rotavirus vaccination program

Vaccine.

Jiang B, Patel M, Glass RI

doi: 10.1016/j.vaccine.2019.04.023.

Further Publications Infectiology

Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial

Vaccine

Beissbarth J, Wilson N, Arrowsmith B, Binks MJ, Oguoma VM, Lawrence K, Llewellyn A, Mulholland EK, Santosham M, Morris PS, Smith-Vaughan HC, Cheng AC, Leach AJ

doi: 10.1016/j.vaccine.2021.03.032

Related content

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18

Who is at risk of 13-valent conjugated pneumococcal vaccine failure?

A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age

Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States

Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016

Polio endgame: Lessons for the global rotavirus vaccination program

Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial